Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Campbell

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Journal of Comparative Effectiveness Research|November 19, 2024
Improving access to gene therapies: a holistic view of current challenges and future policy solutions in the United StatesTyler D Wagner, Lisabeth Buelt, Kimberly Westrich, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 20, 2015
Outcomes before and after treatment escalation to Global Initiative for Asthma steps 4 and 5 in severe asthmaPatrick W Sullivan, Jonathan D Campbell, Vahram H Ghushchyan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 10, 2025
US Drug Pricing Patterns Before Loss of ExclusivityChing-Hsuan Lin, Jonathan D Campbell, James Motyka, et al.
Psychiatric Services (Washington, D.C.)|December 3, 2010
Economic grand rounds: psychological distress and depression associated with job loss and gain: the social costs of job instabilityAnne M Libby, Vahram Ghushchyan, Robert Brett McQueen, et al.
Journal of Medical Economics|July 23, 2013
Cost per responder analysis in patients with secondary hyperparathyroidism on dialysis treated with cinacalcetVasily Belozeroff, Andrew Lee, Spring Tseng, et al.
Clinical Therapeutics|March 13, 2013
Comparative-effectiveness research to aid population decision making by relating clinical outcomes and quality-adjusted life yearsJonathan D Campbell, Judy Zerzan, Louis P Garrison, et al.
JAMA Health Forum|February 9, 2024
Medicare Part D Coverage of Drugs Selected for the Drug Price Negotiation ProgramJulie A Patterson, Tyler D Wagner, John M O'Brien, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 22, 2022
The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19Melanie D Whittington, Steven D Pearson, David M Rind, et al.
Journal of Managed Care & Specialty Pharmacy|March 26, 2021
The effectiveness and value of digital health technologies as an adjunct to medication-assisted therapy for opioid use disorderJeffrey A Tice, Melanie D Whittington, Jonathan D Campbell, et al.
Stroke|May 28, 2015
Cost-Effectiveness of Intra-Arterial Treatment as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic StrokeMichelle H Leppert, Jonathan D Campbell, Jennifer R Simpson, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Journal of Comparative Effectiveness Research|November 19, 2024
Improving access to gene therapies: a holistic view of current challenges and future policy solutions in the United StatesTyler D Wagner, Lisabeth Buelt, Kimberly Westrich, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 20, 2015
Outcomes before and after treatment escalation to Global Initiative for Asthma steps 4 and 5 in severe asthmaPatrick W Sullivan, Jonathan D Campbell, Vahram H Ghushchyan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 10, 2025
US Drug Pricing Patterns Before Loss of ExclusivityChing-Hsuan Lin, Jonathan D Campbell, James Motyka, et al.
Psychiatric Services (Washington, D.C.)|December 3, 2010
Economic grand rounds: psychological distress and depression associated with job loss and gain: the social costs of job instabilityAnne M Libby, Vahram Ghushchyan, Robert Brett McQueen, et al.
Journal of Medical Economics|July 23, 2013
Cost per responder analysis in patients with secondary hyperparathyroidism on dialysis treated with cinacalcetVasily Belozeroff, Andrew Lee, Spring Tseng, et al.
Clinical Therapeutics|March 13, 2013
Comparative-effectiveness research to aid population decision making by relating clinical outcomes and quality-adjusted life yearsJonathan D Campbell, Judy Zerzan, Louis P Garrison, et al.
JAMA Health Forum|February 9, 2024
Medicare Part D Coverage of Drugs Selected for the Drug Price Negotiation ProgramJulie A Patterson, Tyler D Wagner, John M O'Brien, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 22, 2022
The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19Melanie D Whittington, Steven D Pearson, David M Rind, et al.
Journal of Managed Care & Specialty Pharmacy|March 26, 2021
The effectiveness and value of digital health technologies as an adjunct to medication-assisted therapy for opioid use disorderJeffrey A Tice, Melanie D Whittington, Jonathan D Campbell, et al.
Stroke|May 28, 2015
Cost-Effectiveness of Intra-Arterial Treatment as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic StrokeMichelle H Leppert, Jonathan D Campbell, Jennifer R Simpson, et al.
Pageof 13